You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Amgen will use BC Platforms' tools and services to study data in multiple indications, including cardiovascular and bone diseases, hematological malignancies, and other cancers.
Organizers will not only collect genetic data on participants, but report back genetic risks via the country's national health information system.
The project, dubbed FinnGen, was announced this week and is slated to run through mid-2023.
The Office of the National Coordinator for Health IT sees long-term potential in APIs for secure transfer of clinical and genomic data, but it's not quite there yet on the genomic side.
The head of the data center for the Precision Medicine Initiative's All of Us program discusses plans to manage records on 1 million people from dozens of sites.
The companies believe the database can facilitate outcomes research, improve variant interpretations, inform drug development efforts.
Brigham & Women's Ravi Parikh coauthored a recent NEJM commentary calling for a Precision Delivery Initiative to supplement the Precision Medicine Initiative.
An international team of researchers has mapped new associations between HLA mutations and specific diseases, and made their data freely accessible.
Founder Mark Harris and Gillian Hooker, VP of clinical development, explain why a more efficient Genetic Health Information Network is critical to the advancement of precision medicine.
The integration will allow Aprima EHR users to receive alerts about potentially harmful drug-genomic interactions when writing electronic prescriptions.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.